ProfileGDS4718 / 232416_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 27% 25% 28% 33% 19% 25% 24% 29% 26% 28% 25% 27% 25% 25% 21% 27% 25% 26% 27% 21% 28% 25% 28% 28% 24% 25% 30% 23% 20% 32% 30% 27% 28% 25% 18% 21% 34% 29% 28% 22% 22% 32% 22% 24% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.4225727
GSM549102patient 115, normal, homogenized [OPG study]4.3634425
GSM549104patient 119, normal, homogenized [OPG study]4.4573528
GSM549108patient 138, normal, homogenized [OPG study]4.7365633
GSM549119patient 077, normal, homogenized [OPG study]4.0942719
GSM549133patient 032, cancer, homogenized [OPG study]4.2735425
GSM549139patient 042, cancer, homogenized [OPG study]4.2929524
GSM549099patient 107, normal, homogenized [OPG study]4.5364329
GSM549109patient 139, normal, homogenized [OPG study]4.4192126
GSM549110patient 046, normal, homogenized [OPG study]4.446128
GSM549114patient 063, normal, homogenized [OPG study]4.2999225
GSM549122patient 082, normal, homogenized [OPG study]4.4123427
GSM549134patient 033, cancer, homogenized [OPG study]4.3259825
GSM549136patient 036, cancer, homogenized [OPG study]4.277225
GSM549140patient 044, cancer, homogenized [OPG study]4.1569621
GSM549111patient 047, normal, homogenized [OPG study]4.4024727
GSM549113patient 057, normal, homogenized [OPG study]4.2652825
GSM549132patient 031, cancer, homogenized [OPG study]4.3788726
GSM549137patient 038, cancer, homogenized [OPG study]4.4198127
GSM549142patient 047, cancer, homogenized [OPG study]4.2858721
GSM549100patient 110, normal, homogenized [OPG study]4.4670228
GSM549107patient 135, normal, homogenized [OPG study]4.3045425
GSM549115patient 068, normal, homogenized [OPG study]4.3933928
GSM549116patient 072, normal, homogenized [OPG study]4.4416928
GSM549120patient 078, normal, homogenized [OPG study]4.301724
GSM549131patient 030, cancer, homogenized [OPG study]4.2983925
GSM549118patient 074, normal, homogenized [OPG study]4.5425330
GSM549129patient 027, cancer, homogenized [OPG study]4.2906423
GSM549123patient 088, normal, homogenized [OPG study]4.1216920
GSM549124patient 006, cancer, homogenized [OPG study]4.6773132
GSM549126patient 015, cancer, homogenized [OPG study]4.538830
GSM549128patient 025, cancer, homogenized [OPG study]4.3780427
GSM549103patient 117, normal, homogenized [OPG study]4.5086328
GSM549117patient 073, normal, homogenized [OPG study]4.3247925
GSM549138patient 041, cancer, homogenized [OPG study]4.0452218
GSM549141patient 045, cancer, homogenized [OPG study]4.1076121
GSM549130patient 028, cancer, homogenized [OPG study]4.7273834
GSM549101patient 111, normal, homogenized [OPG study]4.5206729
GSM549105patient 128, normal, homogenized [OPG study]4.498628
GSM549106patient 134, normal, homogenized [OPG study]4.1916722
GSM549112patient 048, normal, homogenized [OPG study]4.2037822
GSM549125patient 011, cancer, homogenized [OPG study]4.6476832
GSM549127patient 024, cancer, homogenized [OPG study]4.2070222
GSM549135patient 035, cancer, homogenized [OPG study]4.244324